Molecular & Diagnostic Imaging in Prostate Cancer

Includes chapters on classic imaging methods as well as new image analysis methods and the need for accurate and informed image interpretation
Cutting edge new information is balanced with background information readily understandable for the newcomer and the experienced prostate cancer researcher alike
Unique approach fills a gap in the literature; there are currently no recent comparable and competitive books of this sort

Autorentext
Dr. Heide Schatten is a cell and molecular biologist at University of Missouri-Columbia. She specializes in reproduction and cancers of the reproductive systems. She has been involved as scientist adviser to advocates of Cancer Foundations and as a reviewer and study section leader of several Foundations and she has been a reviewer for the DOD prostate cancer program. She has had Cancer Research support and interacted with a large number of well known prostate cancer researchers including many from NIH Comprehensive Cancer Centers. Her publication record shows over 220 original publications, many of which are focused on cell cycle and cytoskeletal abnormalities that are hallmarks for prostate cancer. She has edited several previous books including (2013) Cell and Molecular Biology of Breast Cancer which has over 19,000 downloads.

Klappentext
The second of two companion books which address the biology and clinical aspects of prostate cancer. This volume, Prostate Cancer: Molecular & Diagnostic Imaging and Treatment Stategies, discusses both classic and the most recent imaging approaches for detection, early diagnosis and treatment of prostate cancer. The companion title, Cell & Molecular Biology of Prostate Cancer, covers classic and modern cell and molecular biology as well as genetics, epigenetics, mitochondrial dysfunctions and apoptosis, cancer stem cells, angiogenesis, progression to metastasis, and treatment strategies including clinical trials related to prostate cancer. Taken together, these volumes form one comprehensive and invaluable contribution to the literature.

Inhalt

1. The role of imaging in clinical prostate cancer Overview of Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Dynamic Contrast-Enhanced MRI (DCE-MRI), MR spectroscopic Imaging (MRSI), Photoacoustic Imaging (PAI).- 2. Automated quantitative cell and tissue imaging technologies.- 3. Diagnostic and early prostate cancer imaging; imaging of advanced prostate cancer.- 4. Emerging radiation techniques.- 5. Radiation therapy and partial prostate irradiation.- 6. Prostate cancer screening: radiology perspectives.- 7. Preclinical imaging of metastasis and dormancy: clinical implications.- 8. Utility of CT in the management of prostate cancer.- 9. Nanotechnology, cancer diagnosis and treatments.- 10. Imaging approaches to distinguish lethal from non-lethal disease.- 11. Photoacoustic imaging.- 12. Molecular and anatomical imaging in drug development.- 13. Molecular imaging modalities including CT, PET, SPECT, MRI, MRS, Hyperpolarized MRI, Ultrasound, X-ray computed tomography, Fusion Imaging (Molecular/Anatomic).- 14. Functional imaging (PET vs. SPECT).- 15. Optical bioluminescence molecular imaging.- 16. Therapeutic radiopharmaceutical translational research imaging.- 17. Accuracy of magnetic resonance imaging for local staging of prostate cancer: diagnostic meta-analysis.- 18. Adjuvant radiotherapy for pathologically advanced prostate cancer: randomized clinical trial.- 19. High-intensity focused ultrasound (HIFU) with histopathological analysis.- 20. Image-directed, tissue-preserving focal therapy of prostate cancer with a novel deformable magnetic resonance-ultrasound (MR-US) registration system.- 21. Focal therapy for localized unifocal and multifocal prostate cancer.- 22. Focal cryotherapy for clinically unilateral, low to intermediate risk prostate cancer.- 23. Impact of obesity on clinico-pathologic outcomes after robot-assisted laparoscopic prostatectomy.- 24. Body mass index, prostate weight and transrectal ultrasound prostate volume accuracy.